Avise SLE+ Connective Tissue 2.0
Gain confidence in your CTD and lupus diagnostics with tests that are smart, convenient and proven.
- Avise SLE+ Connective Tissue 2.0 is a comprehensive diagnostic that offers 33% greater specificity than ANA and 48% greater sensitivity than dsDNA as confirmed by Crithidia.
- Incorporates the power of the biologically rational CB-CAPs technology to deliver a single test with more accurate ability to differentially diagnose SLE and other Connective Tissue Diseases.
- Provides more information to help determine definitive and earlier diagnosis, reduce chance of mis-diagnosis & alleviate patient anxiety.
- Single blood draw, single test requisition, pre-provided kits, pre-paid shipping & easy-to-interpret results returned within 5 business days.
- Covered by Medicare, Medicaid and most private health plans. Exagen also offers a generous financial assistance plan and a variety of convenient payment options to help make Avise diagnostics accessible for everyone. Please call 888.452.1522 for payment assistance.
- Scientific Integrity - the validation behind Avise SLE has been published by the ACR and accepted for publication by Arthritis & Rheumatism which demonstrates the scientific significance of Avise SLE and the integrity with which it was developed and validated.
1. Lupus, Davis Isenberg, Susan Manzi. Oxford University Press 2008.2. Kalunian K et al. The Contribution of Cell Bound Complement Activation Products to the Diagnosis of Systemic Lupus Erythematosus. American College of Rheumatology meeting, Chicago November 5th 2011 (presentation 597).3. Exagen Diagnostics, Inc. – data on file.